Calamos Advisors’s M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant MBAC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-150,000
Closed -$1.55M 1230
2021
Q3
$1.55M Hold
150,000
0.01% 807
2021
Q2
$1.51M Hold
150,000
0.01% 763
2021
Q1
$1.49M Buy
+150,000
New +$1.49M 0.01% 736

Other funds holding MBAC.U

Calamos Advisors's MBAC.U Position: Q4 2021 in Review

Calamos Advisors sold out of M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant (MBAC.U) in Q4 2021, closing a stake of 150,000 shares — an estimated $1.55M sold.

Calamos Advisors first reported a position in MBAC.U in Q1 2021 and held it in 3 quarters. The position peaked at $1.55M in Q3 2021. 16 funds tracked by Wall St. Rank hold MBAC.U as of Q4 2021.

  • Calamos Advisors reported no remaining M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Calamos Advisors sold 150,000 M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant shares in Q4 2021, an estimated $1.55M.
  • Calamos Advisors first reported a position in M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant in Q1 2021 and held it in 3 quarters.
  • Calamos Advisors's M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant position peaked at $1.55M in Q3 2021.
  • 16 funds tracked by Wall St. Rank held M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant as of Q4 2021.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.